Hayley A. McQuilten

Hayley A. McQuilten

Auto-generated profile, based on publicly available information

Hayley A. McQuilten

Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2017 in Cell Reports
Verified
Journal Article
Open access
BRBrendan E. Russ
Brendan E. Russ
MOMoshe Olshansky
Moshe Olshansky
JLJasmine Li
Jasmine Li
MNMichelle L.T. Nguyen
Michelle L.T. Nguyen
LGLinden J. Gearing
Linden J. Gearing
STStephen Turner
Stephen Turner
Infection triggers large-scale changes in the phenotype and function of T cells that are critical for immune clearance, yet the gene regulatory mechanisms that control these changes are largely unknown. Using ChIP-seq for specific histone post-translational modifications (PTMs), we mapped the dynamics of ∼25,000 putative CD8+ T cell transcriptional enhancers (TEs) differentially utilized during virus-specific T cell differentiation. Interestingly, we identified a subset of dynamically regulated TEs that exhibited acquisition of a non-canonical (H3K4me3+) chromatin signature upon differentiation. This unique TE subset exhibited characteristics of poised enhancers in the naive CD8+ T cell subset and demonstrated enrichment for transcription factor binding motifs known to be important for virus-specific CD8+ T cell differentiation. These data provide insights into the establishment and maintenance of the gene transcription profiles that define each stage of virus-specific T cell differentiation.

20 February 2019 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
JCJolie G. Cullen
Jolie G. Cullen
HMHayley A. McQuilten
Hayley A. McQuilten
KQKylie M. Quinn
Kylie M. Quinn
MOMoshe Olshansky
Moshe Olshansky
BRBrendan E. Russ
Brendan E. Russ
STStephen Turner
Stephen Turner
Significance: Promoting effective CD8+T cell memory is a primary goal of T cell-based vaccination and immunotherapy strategies. While it is well established that CD4+T cell help is required for enduring CD8+T cell memory, how such help contributes to establishing optimal CD8+T cell memory generation and persistence remains unclear. In this study, we demonstrate that CD4+help at the time of priming ensures that memory CD8+T cells are programmed to engage metabolic biological pathways essential for effective recall responses. Such understanding has clear implications for the augmentation of vaccine therapies designed to promote protective T cell immunity.

25 September 2023 in Nature Immunology
Verified
Journal Article
Open access
PDF file
Carolien Emma van de SandtCarolien Emma van de Sandt
Carolien Emma van de Sandt
TNThi Hoang Oanh Nguyen
Thi Hoang Oanh Nguyen
NGNicholas A. Gherardin
Nicholas A. Gherardin
JCJeremy Chase Crawford
Jeremy Chase Crawford
JSJerome Samir
Jerome Samir
KKKatherine Kedzierska
Katherine Kedzierska
CD8+ T cells provide robust antiviral immunity, but how epitope-specific T cells evolve across the human lifespan is unclear. Here we defined CD8+ T cell immunity directed at the prominent influenza epitope HLA-A*02:01-M158–66 (A2/M158) across four age groups at phenotypic, transcriptomic, clonal and functional levels. We identify a linear differentiation trajectory from newborns to children then adults, followed by divergence and a clonal reset in older adults. Gene profiles in older adults closely resemble those of newborns and children, despite being clonally distinct. Only child-derived and adult-derived A2/M158+CD8+ T cells had the potential to differentiate into highly cytotoxic epitope-specific CD8+ T cells, which was linked to highly functional public T cell receptor (TCR)αβ signatures. Suboptimal TCRαβ signatures in older adults led to less proliferation, polyfunctionality, avidity and recognition of peptide mutants, although displayed no signs of exhaustion. These data suggest that priming T cells at different stages of life might greatly affect CD8+ T cell responses toward viral infections.

29 May 2023 in Nature Immunology
Verified
Journal Article
Open access
PDF file
WZWuji Zhang
Wuji Zhang
LKLukasz Kedzierski
Lukasz Kedzierski
BCBrendon Y. Chua
Brendon Y. Chua
MMMark Mayo
Mark Mayo
CLClaire Lonzi
Claire Lonzi
KKKatherine Kedzierska
Katherine Kedzierska
High-risk groups, including Indigenous people, are at risk of severe COVID-19. Here we found that Australian First Nations peoples elicit effective immune responses to COVID-19 BNT162b2 vaccination, including neutralizing antibodies, receptor-binding domain (RBD) antibodies, SARS-CoV-2 spike-specific B cells, and CD4+ and CD8+ T cells. In First Nations participants, RBD IgG antibody titers were correlated with body mass index and negatively correlated with age. Reduced RBD antibodies, spike-specific B cells and follicular helper T cells were found in vaccinated participants with chronic conditions (diabetes, renal disease) and were strongly associated with altered glycosylation of IgG and increased interleukin-18 levels in the plasma. These immune perturbations were also found in non-Indigenous people with comorbidities, indicating that they were related to comorbidities rather than ethnicity. However, our study is of a great importance to First Nations peoples who have disproportionate rates of chronic comorbidities and provides evidence of robust immune responses after COVID-19 vaccination in Indigenous people.

10 April 2023 in JCI Insight
Verified
Journal Article
Open access
PDF file
JHJennifer R. Habel
Jennifer R. Habel
BCBrendon Y. Chua
Brendon Y. Chua
LKLukasz Kedzierski
Lukasz Kedzierski
KSKevin J. Selva
Kevin J. Selva
TDTimon Damelang
Timon Damelang
KKKatherine Kedzierska
Katherine Kedzierska
Pregnancy poses a greater risk for severe COVID-19; however, underlying immunological changes associated with SARS-CoV-2 during pregnancy are poorly understood. We defined immune responses to SARS-CoV-2 in unvaccinated pregnant and nonpregnant women with acute and convalescent COVID-19, quantifying 217 immunological parameters. Humoral responses to SARS-CoV-2 were similar in pregnant and nonpregnant women, although our systems serology approach revealed distinct antibody and FcγR profiles between pregnant and nonpregnant women. Cellular analyses demonstrated marked differences in NK cell and unconventional T cell activation dynamics in pregnant women. Healthy pregnant women displayed preactivated NK cells and γδ T cells when compared with healthy nonpregnant women, which remained unchanged during acute and convalescent COVID-19. Conversely, nonpregnant women had prototypical activation of NK and γδ T cells. Activation of CD4 + and CD8 + T cells and T follicular helper cells was similar in SARS-CoV-2–infected pregnant and nonpregnant women, while antibody-secreting B cells were increased in pregnant women during acute COVID-19. Elevated levels of IL-8, IL-10, and IL-18 were found in pregnant women in their healthy state, and these cytokine levels remained elevated during acute and convalescent COVID-19. Collectively, we demonstrate perturbations in NK cell and γδ T cell activation in unvaccinated pregnant women with COVID-19, which may impact disease progression and severity during pregnancy.

8 March 2021 in JCI Insight
Verified
Journal Article
Open access
PDF file
GDGeorgia Deliyannis
Georgia Deliyannis
CWChinn Yi Wong
Chinn Yi Wong
HMHayley A. McQuilten
Hayley A. McQuilten
ABAnnabell Bachem
Annabell Bachem
MCMichele Clarke
Michele Clarke
BCBrendon Y. Chua
Brendon Y. Chua
The impact of respiratory virus infections on global health is felt not just during a pandemic, but endemic seasonal infections pose an equal and ongoing risk of severe disease. Moreover, vaccines and antiviral drugs are not always effective or available for many respiratory viruses. We investigated how induction of effective and appropriate antigen-independent innate immunity in the upper airways can prevent the spread of respiratory virus infection to the vulnerable lower airways. Activation of TLR2, when restricted to the nasal turbinates, resulted in prompt induction of innate immune–driven antiviral responses through action of cytokines, chemokines, and cellular activity in the upper but not the lower airways. We have defined how nasal epithelial cells and recruitment of macrophages work in concert and play pivotal roles to limit progression of influenza virus to the lungs and sustain protection for up to 7 days. These results reveal underlying mechanisms of how control of viral infection in the upper airways can occur and support the implementation of strategies that can activate TLR2 in nasal passages to provide rapid protection, especially for at-risk populations, against severe respiratory infection when vaccines and antiviral drugs are not always effective or available.